Amdark Limited Strengthens Investment Fraud Recovery Services as Online Scams Surge
Globe PR Wire
Today at 10:19am UTC
Satellite Manufacturing and Launch Systems Market to Reach $130.2 billion, Globally, by 2033 at 18.7% CAGR: Allied Market Research
PR Newswire
Today at 9:47am UTC
Four Seasons Education to Report First Half of Fiscal Year 2026 Unaudited Financial Results
PR Newswire
Today at 9:45am UTC
Bybit Advances Regulatory Dialogue at Argentina's Regulation Day 2025, Spotlighting Crypto's Role in Financial Inclusion
Chainwire
Today at 9:38am UTC
Bybit Advances Regulatory Dialogue at Argentina's Regulation Day 2025, Spotlighting Crypto's Role in Financial Inclusion
NewsDirect
Today at 9:38am UTC
Luvme Hair 2025 Black Friday Best Savings in Three Days
GlobeNewswire
Today at 9:38am UTC
12th Meeting of the Council of ASEAN Chief Justices
PR Newswire
Today at 9:34am UTC
Singapore no. 1 in global competition for talent
PR Newswire
Today at 9:30am UTC
atNorth's DEN01 Data Center to supply heat to Danish homes in collaboration with Vestforbrænding
PR Newswire
Today at 9:28am UTC
EHang Reports Third Quarter 2025 Unaudited Financial Results
GlobeNewswire
Today at 9:16am UTC
Kanazawa University research: Scientists develop light-controlled method to trigger brain signals
PR Newswire
Today at 9:14am UTC
Blueberry announces strategic global partnership with Australia's SailGP team, the Bonds Flying Roos
PR Newswire
Today at 9:14am UTC
/C O R R E C T I O N -- Global Drama Association/
PR Newswire
Today at 9:09am UTC
Lifestyle Expert Bethany Braun-Silva Shares Holiday Style & Gift Ideas on YourUpdateTV
GlobeNewswire
Today at 9:07am UTC
Calgary Commercial Property Owners Adopt Roof Insulation to Manage Energy Use
Press Services
Today at 9:00am UTC
Hisense Tops Global 100-inch and Laser TV Markets in Q3 2025
PR Newswire
Today at 9:00am UTC
Norsk Hydro: Hydro to close five European extrusion plants
GlobeNewswire
Today at 9:00am UTC
Cheetah Mobile Announces Third Quarter 2025 Unaudited Consolidated Financial Results
PR Newswire
Today at 9:00am UTC
Tangram Therapeutics Submits Clinical Trial Application for Phase 1/2 Study of TGM-312, a Novel Investigational RNAi MASH Candidate
GlobeNewswire
Today at 9:00am UTC
Fractus expands licensing program into point-of-sale (POS) vertical
PR Newswire
Today at 9:00am UTC